172
Views
6
CrossRef citations to date
0
Altmetric
Original Research

The influence of excipients on physical and pharmaceutical properties of oral lyophilisates containing a pregabalin-acetaminophen combination

ORCID Icon, , , , , , , & show all
Pages 589-599 | Received 05 Oct 2016, Accepted 01 Feb 2017, Published online: 20 Feb 2017

References

  • Cartilier LH, Moes AJ. Effect of drug agglomerates upon the kinetics of mixing of low-dosage cohesive powder mixtures. Drug Dev Ind Pharm. 1989;15:1911–1931.
  • Garcia TP, Prescott JK. Blending and Blend Uniformity. In: Augsburger LL, Hoag SW, editors. Pharmaceutical Dosage Forms: Tablets; 2008. p. 111–174.
  • Grigorov PI, Glasser BJ, Muzzio FJ. Formulation and manufacture of pharmaceuticals by fluidized-bed impregnation of active pharmaceutical ingredients onto porous carriers. Aiche Journal. 2013;59:4538–4552.
  • Saffari M, Ebrahimi A, Langrish T. A novel formulation for solubility and content uniformity enhancement of poorly water-soluble drugs using highly-porous mannitol. Eur J Pharm Sci. 2016;83:52–61.
  • Kumar D, Dureja H. Pharmaceutical excipients: global regulatory issues. Indonesian J Pharm. 2013;24(4):215–221.
  • Excipient applications in formulation design and drug delivery. Narang AS, Boddu SHS, editors. © Cham: Springer International Publishing Switzerland; 2015. DOI: 10.1007/978-3-319-20206-8. ISBN 978-3-319-20205-1 ISBN 978-3-319-20206-8. (eBook).
  • Vanhoorne V, Bekaert B, Peeters E, et al. Improved tabletability after a polymorphic transition of delta-mannitol during twin screw granulation. Int J Pharm. 2016;506(1–2):13–24.
  • Hulse RT, Forbes MC, Bonner MG. The characterization and comparison of spray-dried mannitol samples. Drug Dev Ind Pharm. 2009;35:712–718.
  • Yoshinari T, Roberts RT, York P, et al. The improved compaction properties of mannitol after a moisture induced polymorphic transition. Int J Pharm. 2003;258:121–131.
  • Wagner CM, Pein M, Breitkreutz J. Roll compaction of granulated mannitol grades and the unprocessed crystalline delta-polymorph. Pow Tech. 2015;270:470–475.
  • Al-Khattawi A, Mohammed AR. Compressed orally disintegrating tablets: excipients evolution and formulation strategies. Expert Opin Drug Deliv. 2013;10(5):651–663. DOI:10.1517/17425247.2013.769955
  • Kajiharaa R, Noguchia S, Iwaoa Y, et al. Structural investigation of spherical hollow excipient Mannit Q by X-ray microtomography. Int J Pharm. 2015;495:140–143.
  • Jannin V, Pochard E, Chambin O. Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing Precirol ATO 5. Int J Pharm. 2006;309(1–2):6–15.
  • Savolainen M, Herder J, Khoo C, et al. Evaluation of polar lipid-hydrophilic polymer microparticles. Int J Pharm. 2003;262(1–2):47–62.
  • Sonia CS, Marıa PB, Beatriz EE. Carotene encapsulation in a mannitol matrix as affected by divalent cations and phosphate anion. Int J Pharm. 2007;332:45–54.
  • Jezek J, Darton NJ, Derham BK, et al. Biopharmaceutical formulations for pre-filled delivery devices. Expert Opin Drug Deliv. 2013;10(6):811–828.
  • Izutsu K, Kojima S. Excipient crystallinity and its protein structure stabilizing effect during freeze drying. J Pharm Pharmacol. 2002;54:1033–1039.
  • Izutsu K, Ocheda SO, Aoyagi N, et al. Effects of sodium tetraborato and boric acid on nonisothermal mannitol crystallization in frozen solutions and freeze-dried solids. Int J Pharm. 2004;273:85–93.
  • Nail SL, Jiang S, Chongprasert S, et al. Fundamentals of freeze-drying. Pharm Biotechnol. 2002;14:281–360.
  • Telang C, Yu I, Suryanarayanan R. Effective inhibition of mannitol crystallization in frozen solutions by sodium chloride. Pharm Res. 2003;20:660–667.
  • Cavatur RK, Vemuri NM, Pyne A, et al. Crystallization behavior of mannitol in frozen aqueous solutions. Pharm Res. 2002;19:894–900.
  • Brennan F, Obs D, Carr D, et al. Pain management: a fundamental human right. Anesthesia & Analgesia. 2007;105(1):205–221.
  • Chronic pain medication treatment guidelines, American Association for the Study of Pain, https://www.dir.ca.gov/dwc/DWCPropRegs/MTUS_Regulations/MTUS_ChronicPainMedicalTreatmentGuidelines.pdf
  • Dahl JB, Nielsen RV, Wetterslev J, et al. Post-operative analgesic effects of paracetamol, NSAIDs, glucocorticoids, gabapentinoids and their combinations: a topical review. Acta Anaesthesiol Scand. 2014;58:1165–1181.
  • Kehlet H, Dahl JB. Anaesthesia, surgery, and challenges in postoperative recovery. Lancet. 2003;362:1921–1928.
  • Dahl JB, Mathiesen O, Kehlet H. An expert opinion on postoperative pain management, with special reference to new developments. Expert Opin Pharmacother. 2010;11:2459–2470.
  • Ibrahim AA, Chwan-Fwu L, Chun-Han C, et al. The codrug approach for facilitating drug delivery and bioactivity. Expert Opin Drug Deliv. 2016;13(9):1311–1325.
  • Zhang Y, Du L, Pan H, et al. Enhanced analgesic effects of propacetamol and tramadol combination in rats and mice. Biol Pharm Bull. 2011;34(3):349—353.
  • Van Laar M, Pergolizzi JV Jr, Mellinghoff H-U, et al. Pain treatment in arthritis-related pain: beyond NSAIDs. Open Rheumatol J. 2012;6:320–330.
  • Jackson KC. Pharmacotherapy for neuropathic pain. Pain Pract. 2006;6(1):27–33.
  • Verma V, Singh N, Singh JA. Pregabalin in neuropathic pain: evidences and possible mechanisms. Curr Neuropharmacol. 2014;12(1):44-56(13).
  • Ong CK, Seymour RA, Lirk P, et al. Combining paracetamol (acetaminophen) with nonsteroidal antiinflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesth Analg. 2010;110(4):1170–1179.
  • Tassone DM, Boyce E, Guyer J, et al. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders. Clin Ther. 2007;29(1):26–48.
  • Mititelu-Tartau L, Popa EG, Lupusoru RV, et al. Synergic effects of pregabalin-acetaminophen combination in somatic and visceral nociceptive reactivity. Pharmacology (Karger). 2014;93(5–6):253–259.
  • Popa G, Mititelu Tartau L, Lupusoru RV, et al. The synergistic antinociceptive interaction of codeine and pregabalin in a somatic pain model in mice. Farmacia. 2014;62(5):882–890.
  • Paramita D, Sabyasachi M. Orodispersible tablets: a new trend in drug delivery. J Nat Scibiol Med. 2010;1(1):2–5.
  • Ahmed IS, Shamma RN, Shoukri RA. Development and optimization of lyophilized orally disintegrating tablets using factorial design. Pharm Dev Technol. 2013;18(4):935–943.
  • Chandrasekhar R, Zahra H, AlHusban F. The role of formulation excipients in the development of lyophilized fast-disintegrating tablets. Eur J Pharm Biopharm. 2009;72(1):119–129.
  • Siow CRS, Wan Sia Heng P, Chan LW. Application of freeze-drying in the development of oral drug delivery systems. Expert Opin Drug Deliv. 2016;13:1595–1608. DOI:10.1080/17425247.2016.1198767
  • Lungan MA, Popa M, Desbrieres J, et al. Complex multiparticulate systems based on glycidyl methacrylate and xanthan. Carbohydr Polym. 2014;104:213–222.
  • Cook J, Addicks W, Wu YH. Application of the biopharmaceutical classification system in clinical drug development-an industrial view. The AAPS Journal. 2008;10(2):306–310.
  • Kalantzi L, Reppas C, Dressman JB, et al. Biowaiver monographs for immediate release solid oral dosage forms: acetaminophen (paracetamol). J Pharm Sci. 2006;95:4–14.
  • Bali A, Gaur P. A novel method for spectrophotometric determination of pregabalin in pure form and in capsules. Chem Cent J. 2011;5(59):59–65.
  • Pabari R, Ramtoola Z. Effect of a disintegration mechanism on wetting, water absorption, and disintegration time of orodispersible tablets. J Young Pharm. 2012;4(3):157–163. DOI:10.4103/0975-1483.100021
  • Kumaresan G, Velraj R, Iniyan S. Thermal analysis of D-mannitol for use as phase change material for latent heat storage. J Appl Sci. 2011;11:3044–3048.
  • Tong B, Liu RB, Meng CG, et al. Nonisothermal thermal decomposition reaction kinetics of D-mannitol. J Chem Eng Data. 2010;55:119–124.
  • Handbook of Pharmaceutical Excipients. 6th. In: Rowe RC, Sheskey PJ, Quinn ME, eds. London: Pharmaceutical Press; 2009. p. 424.
  • Tomassetti M, Catalani A, Rossi V, et al. Thermal analysis study of the interactions between acetaminophen and excipients in solid dosage forms and in some binary mixtures. J Pharm Biomed Anal. 2005;37:949–955.
  • Gerich A, Dubois J, Kidder LH. NIR imaging applications in the pharmaceutical industry. In: Šašić S, Ozaki Y, editors. Raman, infrared, and near-infrared chemical imaging. Hoboken (NJ): John Wiley & Sons, Inc.; 2010. DOI:10.1002/9780470768150.ch11
  • Nita LE, Chiriac AP, Bercea M, et al. Static and dynamic investigations of poly(aspartic acid) and PluronicF127 complex prepared by self-assembling in aqueous solution. Appl Surf Sci. 2015;359:486–495.
  • Lewis EN, Carroll JE, Clarke FM, et al. Infrared view of pharmaceutical formulation analysis. NIR News. 2001;12:16–18.
  • Chiriac AP, Nita LE, Tartau L, et al. Semi -imprinting quercetin into poly[N,N-Dimethylacrylamide-co-3, 9-divinyl-2, 4, 8, 10-Tetraoxaspiro (5.5) Undecane] network: evaluation of the antioxidant character. J Pharm Sci. 2014;103:2338–2346.
  • Nita LE, Chiriac AP, Mititelu-Tartau L, et al. Patterning poly(maleicanhydride-co-3,9-divinyl-2,4,8,10-tetraoxaspiro (5.5) undecane)copolymer bioconjugates for controlled release of drugs. Intern J Pharmaceutics. 2015;493:328–340.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.